Cristina Suarez discusses the biggest RCC trials and treatments of 2023, including LITESPARK-022.
Dr. Suarez is an oncologist at Vall D’Hebron Institute of Oncology and serves as Senior Researcher of VHIO´s Genitourinary, Central Nervous System Tumors, Sarcoma and Cancer of Unknown Primary Site Group.